Preventive effect of oral estetrol in a menopausal hot flush model

Climacteric

Volumn 11, Issue SUPPL. 1, 2008, Pages 15-21

  Holinka, C F ^a   Brincat, M ^b   Coelingh Bennink, H J T ^c  

^a PharmConsult   (United States)

^b UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

^c Pantarhei Bioscience   (Netherlands)

Author keywords

E4; Estetrol; Hot flush; Vasomotor symptoms

Indexed keywords

ESTETROL; ETHINYLESTRADIOL; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HOT FLUSH; MENOPAUSAL SYNDROME; MENOPAUSE; MORPHINE ADDICTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SKIN TEMPERATURE; SYMPTOM; THERMOREGULATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTETROL; FEMALE; HOT FLASHES; HUMANS; MODELS, ANIMAL; MODELS, BIOLOGICAL; MORPHINE; NALOXONE; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SKIN TEMPERATURE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 39149092440     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701822807     Document Type: Article

References (31)

1. Prior JC. Perimenopause: The complex endocrinology of the menopausal transition. Endocr Rev 1998;19:397-428
2. Meldrum DR, Shamonki IM, Frumar AM, et al. Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: standardization of the technique. Am J Obstet Gynecol 1979;135:713-17
3. Meldrum DR, Tataryn IV, Frumar AM, et al. Gonadotropins, estrogens and adrenal steroids during the menopausal hot flash. J Clin Endocrinol Metab 1980;50:685-9
4. Rossmanith WG. Gonadotropin secretion during aging in women: review article. Exp Gerontol 1995;30:369-81
5. Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 2005;118:74-8S
6. Nachtigall LE, Baber RJ, Barentsen R, et al. Complementary and hormonal therapy for vasomotor symptom relief: a conservative approach. J Obstet Gynaecol Can 2006;28:279-89
7. Swanson SG, Drosman S, Helmond FA, Stathopoulos VM. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multi-center, randomized, double-blind, placebo-controlled study. Menopause 2006;13:917-25
8. Panay N. Integrating phytoestrogens with prescription medicines - a conservative clinical approach to vasomotor symptom management. Maturitas 2007;57:90-4
9. Hickey M, Saunders CM, Stuckey BGA. Nonhormonal treatments for menopausal symptoms. Maturitas 2007;57:85-9
10. Hagen AA, Barr M, Diczfalusy E. Metabolism of 17β-oestradiol-4-14C in early infancy. Acta Endocrinol 1965;49:207-20
11. Gurpide E, Schwers J, Welch MT, Van de Wiele RL, Lieberman S. Fetal and maternal metabolism of estradiol during pregnancy. J Clin Endocrinol Metab 1966;26:1355-65
12. Heikkilä J, Adlercreutz H. A method for the determination of urinary 15α-hydroxyestriol and estriol. J Steroid Biochem 1970;1:243-53
13. Heikkilä J. Excretion of 15α-hydroxyestriol and estriol in maternal urine during normal pregnancy. J Steroid Biochem 1971;2:83-93
14. Tulchinsky D, Frigoletto FD, Ryan KJ, Fishman J. Plasma estetrol as an index of fetal well-being. J Clin Endocrinol Metab 1975;40:560-7
15. Kundu N, Wachs M, Iverson GB, Petersen LP. Comparison of serum unconjugated estriol and estetrol in normal and complicated pregnancies. Obstet Gynecol 1981;58:276-81
16. Tseng L, Gurpide E. Competition of estetrol and ethinylestradiol with estradiol for nuclear binding in human endometrium. J Steroid Biochem 1976;7:817-22
17. Tseng L, Gurpide E. Heterogeneity of saturable estradiol binding sites in nuclei of human endometrium; estetrol studies. J Steroid Biochem 1978;9:1145-8
18. Martucci C, Fishman J. Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15α,16α, 17β-tetrol). Steroids 1976;27:325-33
19. Holinka CF, Gurpide E. In vivo effects of estetrol on the immature rat uterus. Biol Reprod 1979;20:242-6
20. Holinka CF, Bressler RS, Zehr DR, Gurpide E. Comparison of effects of estetrol and tamoxifen with those of estriol and estradiol on the immature rat uterus. Biol Reprod 1980;22:913-26
21. Jozan S, Kreitmann B, Bayard F. Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term culture. Acta Endocrinol 1981;98:73-80
22. Holinka CF, Diczfalusy E, Coelingh Bennink HJT. Estetrol: a unique steroid in human pregnancy. J Steroid Biochem Molec Biol 2008;in press
23. Simpkins JW, Katovich MJ, Song I-C. Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sci 1983;32:1957-66
24. Katovich MJ, O'Meara J. Effect of chronic estrogen on skin temperature response to naloxone in morphine-dependent rats. Can J Physiol Pharmacol 1987;65:563-7
25. Coelingh Bennink HJT, Heegaard A-M, Visser M, Holinka CF, Christiansen C. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric 2008;11(Suppl 1):2-14
26. Visser M, Holinka CF, Coelingh Bennink HJT. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women. Climacteric 2008;11(Suppl 1):31-40
27. Katovich MJ, Simpkins JW, Berglund LA. O'Meara J. Regional skin temperature changes in a rat model for the menopausal hot flush. Maturitas 1986;8:67-78
28. Merchenthaler I, Funkhouser JM, Carver JM, Lundeen SG, Ghosh K, Winneker RC. The effect of estrogens and antiestrogens in a rat model for hot flush. Maturitas 1998;30:307-16
29. Berendsen HH, Weekers AH, Kloosterboer HJ. Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol 2001;419:47-54
30. Pan Y, Anthony MS, Binns M, Clarkson TB. A comparison of oral micronized estradiol with soy phytoestrogen effects on tail skin temperature of ovariectomized rats. Menopause 2001;8:171-4
31. Coelingh Bennink HJT, Holinka CF, Diczfalusy E. Estetrol review: profile and potential clinical applications. Climacteric 2008;11(Suppl 1):47-58